| __timestamp | Protagonist Therapeutics, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 1860000 | 612613000000 |
| Thursday, January 1, 2015 | 2963000 | 650773000000 |
| Friday, January 1, 2016 | 6961000 | 619061000000 |
| Sunday, January 1, 2017 | 11779000 | 628106000000 |
| Monday, January 1, 2018 | 13697000 | 717599000000 |
| Tuesday, January 1, 2019 | 15749000 | 964737000000 |
| Wednesday, January 1, 2020 | 18638000 | 875663000000 |
| Friday, January 1, 2021 | 27196000 | 886361000000 |
| Saturday, January 1, 2022 | 31739000 | 997309000000 |
| Sunday, January 1, 2023 | 33491000 | 1053819000000 |
| Monday, January 1, 2024 | 1053819000000 |
Unveiling the hidden dimensions of data
In the world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability and growth. This chart compares the SG&A expenses of Takeda Pharmaceutical Company Limited and Protagonist Therapeutics, Inc. from 2014 to 2023. Takeda, a global leader, consistently shows SG&A expenses in the range of hundreds of billions, reflecting its expansive operations and market reach. In contrast, Protagonist Therapeutics, a smaller player, has seen its SG&A expenses grow from approximately $1.9 million in 2014 to over $33 million in 2023, marking a staggering increase of over 1,600%. This growth highlights Protagonist's expanding footprint in the industry. Notably, Takeda's expenses peaked in 2023, reaching over a trillion, indicating strategic investments or expansions. The data for 2024 is incomplete, suggesting ongoing developments. This comparison underscores the diverse strategies and scales of operation within the pharmaceutical sector.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited vs Ascendis Pharma A/S: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Alkermes plc or Protagonist Therapeutics, Inc.
PTC Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: MorphoSys AG vs Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Protagonist Therapeutics, Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Breaking Down SG&A Expenses: Protagonist Therapeutics, Inc. vs Dynavax Technologies Corporation
Protagonist Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Protagonist Therapeutics, Inc. vs Novavax, Inc.
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Celldex Therapeutics, Inc.